AR022090A1 - PARTICLES FOR THE ADMINISTRATION OF AN ACTIVE AGENT TO THE HUMAN PATIENT ALVELS, A METHOD FOR THEIR PREPARATION, AND THE USE OF THE SAME FOR THE PREPARATION OF AN INHALATION MEDICATION - Google Patents
PARTICLES FOR THE ADMINISTRATION OF AN ACTIVE AGENT TO THE HUMAN PATIENT ALVELS, A METHOD FOR THEIR PREPARATION, AND THE USE OF THE SAME FOR THE PREPARATION OF AN INHALATION MEDICATIONInfo
- Publication number
- AR022090A1 AR022090A1 ARP990104587A ARP990104587A AR022090A1 AR 022090 A1 AR022090 A1 AR 022090A1 AR P990104587 A ARP990104587 A AR P990104587A AR P990104587 A ARP990104587 A AR P990104587A AR 022090 A1 AR022090 A1 AR 022090A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- particles
- active agent
- administration
- human patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
Partículas para la administracion de un agente activo a los alvéolos de un paciente humano, partículas que contienen el agente activo y un inhibidor delcrecimiento higroscopico, donde el inhibidor del crecimiento higroscopico está incorporado al interior de las partículas donde las partículas exhiben una caídade la dosis emitida, en condiciones pulmonares simuladas, de no más de aproximadamente 25%.Particles for the administration of an active agent to the alveoli of a human patient, particles containing the active agent and a hygroscopic growth inhibitor, where the hygroscopic growth inhibitor is incorporated into the particles where the particles exhibit a fall in the emitted dose , in simulated lung conditions, of no more than approximately 25%.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10016398P | 1998-09-14 | 1998-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022090A1 true AR022090A1 (en) | 2002-09-04 |
Family
ID=22278404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990104587A AR022090A1 (en) | 1998-09-14 | 1999-09-13 | PARTICLES FOR THE ADMINISTRATION OF AN ACTIVE AGENT TO THE HUMAN PATIENT ALVELS, A METHOD FOR THEIR PREPARATION, AND THE USE OF THE SAME FOR THE PREPARATION OF AN INHALATION MEDICATION |
Country Status (44)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE555773T1 (en) | 1999-06-09 | 2012-05-15 | Sievers Robert E | SUPERCRITICAL FLUID-ASSISTED NEBULIZATION AND BUBBLES DRYING |
| US6475468B2 (en) * | 2001-02-15 | 2002-11-05 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| EP1392262A1 (en) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| EG24184A (en) * | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| EA200401111A1 (en) | 2002-02-25 | 2005-02-24 | Диффьюжн Фармасьютикалз Ллс | TRANS-CAROTINOID BIPOLAR SALTS AND THEIR APPLICATION |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| JP2006513139A (en) * | 2002-07-03 | 2006-04-20 | ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド | Central airway administration for systemic delivery of therapeutic agents |
| MXPA05006802A (en) * | 2002-12-19 | 2005-09-08 | Pharmacia Corp | Non-hygroscopic formulation comprising a hydroscopic drug. |
| DE10338403A1 (en) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| CN101098678A (en) | 2004-04-23 | 2008-01-02 | 锡德克斯公司 | Dpi formulation containing sulfoalkyl ether cyclodextrin |
| EP1853544A4 (en) | 2005-02-24 | 2010-06-16 | Diffusion Pharmaceuticals Llc | Trans carotenoids, their synthesis, formulation and uses |
| EP1857114A1 (en) * | 2005-03-09 | 2007-11-21 | Ono Pharmaceutical Co., Ltd. | Particle and preparation containing the particle |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| DK2581078T3 (en) | 2005-10-26 | 2015-03-02 | Cydex Pharmaceuticals Inc | Sulfoalkylætercyclodekstrinsammensætninger and processes for the preparation thereof |
| WO2008021451A2 (en) * | 2006-08-14 | 2008-02-21 | Aktiv-Dry Llc | Human-powered dry powder inhaler and dry powder inhaler compositions |
| EP2095812A4 (en) * | 2006-10-25 | 2011-07-13 | Dainippon Sumitomo Pharma Co | Granular preparation prevented from caking |
| EP1925295A1 (en) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stable powder formulation containing a new antichinolinergic agent |
| US8293804B2 (en) | 2007-04-13 | 2012-10-23 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
| JP2011502125A (en) | 2007-10-31 | 2011-01-20 | ディフュージョン・ファーマシューティカルズ・エルエルシー | A new class of treatments that promote small molecule diffusion |
| EP2432502B1 (en) | 2009-05-20 | 2018-01-03 | Aeras | Stable, spray dried, immunogenic, viral compositions |
| CA2765697C (en) | 2009-06-22 | 2019-11-12 | Diffusion Pharmaceuticals Llc | Diffusion enhancing compounds and their use alone or with thrombolytics |
| CN103124498A (en) | 2010-06-02 | 2013-05-29 | 扩散药品有限公司 | Oral formulations of bipolar trans carotenoids |
| AU2013255885C1 (en) | 2012-05-03 | 2018-04-26 | Janssen Sciences Ireland Uc | Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections |
| BR112015010601B1 (en) * | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION |
| US20180043585A9 (en) * | 2013-09-20 | 2018-02-15 | Virginia Commonwealth University | Delivery of particles using hygroscopic excipients |
| ES2841933T3 (en) | 2014-10-31 | 2021-07-12 | Univ Monash | Powder formulation |
| KR20230014850A (en) | 2016-03-24 | 2023-01-30 | 디퓨젼 파마슈티컬즈 엘엘씨 | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155573A (en) * | 1958-05-06 | 1964-11-03 | Benger Lab Ltd | Inhalant composition and method of making same |
| WO1993025198A1 (en) * | 1992-06-12 | 1993-12-23 | Teijin Limited | Ultrafine powder for inhalation and production thereof |
| US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| ATE287257T1 (en) * | 1997-01-16 | 2005-02-15 | Massachusetts Inst Technology | PREPARATION OF PARTICLE-CONTAINING MEDICINAL PRODUCTS FOR INHALATION |
| US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
-
1999
- 1999-09-09 MA MA25762A patent/MA25590A1/en unknown
- 1999-09-13 CN CN99810871A patent/CN1317977A/en active Pending
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/en unknown
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/en unknown
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 TW TW088115876A patent/TWI226248B/en not_active IP Right Cessation
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/en active
- 1999-09-13 UA UA2001031707A patent/UA76085C2/en unknown
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/en not_active Application Discontinuation
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/en unknown
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 YU YU24201A patent/YU24201A/en unknown
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/en not_active Application Discontinuation
- 1999-09-13 EA EA200100300A patent/EA003476B1/en active IP Right Revival
- 1999-09-13 IL IL14156299A patent/IL141562A0/en not_active IP Right Cessation
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/en unknown
- 1999-09-13 EP EP99969035A patent/EP1117442A1/en not_active Withdrawn
- 1999-09-13 CA CA002343920A patent/CA2343920A1/en not_active Abandoned
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/en not_active Application Discontinuation
- 1999-09-13 ID IDW20010582A patent/ID28845A/en unknown
- 1999-09-13 PL PL99346768A patent/PL195574B1/en not_active IP Right Cessation
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/en not_active IP Right Cessation
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 AR ARP990104587A patent/AR022090A1/en unknown
- 1999-09-13 EE EEP200100151A patent/EE200100151A/en unknown
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/en unknown
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/en not_active Withdrawn
- 1999-09-14 CO CO99058265A patent/CO5130023A1/en unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/en not_active Application Discontinuation
- 1999-09-14 GT GT199900156A patent/GT199900156A/en unknown
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/en unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/en unknown
- 1999-10-31 SA SA99200718A patent/SA99200718B1/en unknown
-
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/en unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/en not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/en not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/en unknown
- 2001-03-14 HR HR20010189A patent/HRP20010189A2/en not_active Application Discontinuation
- 2001-04-10 BG BG105430A patent/BG105430A/en unknown
-
2002
- 2002-03-06 HK HK02101738.3A patent/HK1042231A1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR022090A1 (en) | PARTICLES FOR THE ADMINISTRATION OF AN ACTIVE AGENT TO THE HUMAN PATIENT ALVELS, A METHOD FOR THEIR PREPARATION, AND THE USE OF THE SAME FOR THE PREPARATION OF AN INHALATION MEDICATION | |
| CY1110376T1 (en) | USE OF A COMPOSITION INCLUDING FORMOTEROL AND BUDESONIDE TO PREVENT OR THERAPEUTIC IMMUNITY | |
| ES2136618T3 (en) | WOUND HEALING. | |
| MX9300620A (en) | PHARMACEUTICAL FORMULATION IN AEROSOL AND INHALER FOR THE ADMINISTRATION OF BECLOMETASONE DIPROPIONATE. | |
| ES2164040T1 (en) | USE OF AGONISTS OF THE GLICINE UNION SITE OR INHIBITORS OF GLYCIN ABSORPTION FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS. | |
| AR037629A1 (en) | PHARMACEUTICAL FORMULATIONS THAT INCLUDE A PLATINUM DERIVATIVE | |
| NO20053105L (en) | Oral, extended-release analgesic dosage form for administration ± once per day. day. | |
| CR6458A (en) | VALDECOXIB COMPOSITIONS | |
| JO2381B1 (en) | Formulations containing an antich holinergic drug for the treatment of chronic obstructive pulmonary disease | |
| DE69205177T2 (en) | Pharmaceutical aerosol formulation. | |
| ES2082288T3 (en) | THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLACO. | |
| ES2150022T3 (en) | PHARMACEUTICAL AEROSOL CONTAINING AT LEAST ONE SUGAR. | |
| DE69417733D1 (en) | METHOD FOR INHIBITING BONE LOSS WITH 3,4-DIARYLCHROMAN | |
| AR002754A1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING MICRO-ENCAPSULATED VIABLE LACTOBACILLUS BACTERIA, AND USE OF THE COMPOSITION TO PREPARE A MEDICINAL PRODUCT | |
| KR900009057A (en) | Medical Aerosol Formulations | |
| CO5611092A2 (en) | FORMOTEROL SUPERFINE FORMULATION | |
| AR037592A1 (en) | PHARMACEUTICAL FORMULATIONS OF 5,7,14-TRIAZATETRACICLO (10.3.1.02,11.04,9) -HEXADECA-2 (11), 3,5,7,9-PENTAENO | |
| KR910009242A (en) | Sustained release compositions for treatment of periodontal disease | |
| ATE146677T1 (en) | PHARMACEUTICAL FORMULATION FOR TREATING NICOTINE DEPENDENCE | |
| BR0109672A (en) | Use of zd6126 or a pharmaceutically acceptable salt thereof and one of: a plantin antitumor agent and a taxane, pharmaceutical composition, combination product, kit, and method for producing a vascularly damaging effect on a warm-blooded animal | |
| AR020803A1 (en) | A COMPOSITION THAT INCLUDES FEXOFENADINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINE | |
| BRPI0414500A (en) | pharmaceutical formulation composition to treat a vaginal infection, and methods to treat a vaginal infection, to stabilize a clindamycin formulation, to treat or prevent a recurrence of a vaginal infection in a patient and to treat vaginal conditions | |
| ES2184145T3 (en) | SULPHONIC ACID OR SULFONYLAMINE ACIDS-N- (HETEROARALQUIL) -AZAHETEROCICLILAMIDA. | |
| AR033403A1 (en) | USE OF REOVIRUS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO REDUCE A SOLID TUMOR MASS. | |
| CO5580741A2 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A 5HT1 RECEIVER AGONIST |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |